医薬品の評価

Overview of ecallantide in the treatment of hereditary angioedema types I and II

Erin Banta and Timothy J Craig

• 抽象的な

医薬品の評価

Micafungin in a nutshell: state of affairs on the pharmacological and clinical aspects of the novel echinocandin

Fedja Farowski, Jorg J Vehreschild, Oliver A Cornely and Maria JGT Vehreschild

• 抽象的な

ショートレポート

Neuro-QOL and the NIH Toolbox: implications for epilepsy

Cindy J Nowinski, David Victorson, Jose E Cavazos, Richard Gershon and David Cella

• 抽象的な

ショートレポート

Post-traumatic epilepsy: an overview

Rebecca M Verellen and Jose E Cavazos

• 抽象的な

総説

Antiepileptic drug pregnancy registries: do the latest findings concur?

Leticia Tornes and Cynthia L Harden

• 抽象的な

総説

Neuropsychiatric issues in patients with epilepsy: focus on depression

Taoufik Alsaadi

• 抽象的な

総説

Approach to refractory childhood seizures

Blathnaid McCoy and Selim R Benbadis

• 抽象的な

総説

Efficacy of electrical brain stimulation in epilepsy

Peter Widdess-Walsh, Christoph Kellinghaus, Eric Geller, Frank Bosebeck, Stephan Schuele and Tobias Loddenkemper

• 抽象的な

総説

Surgical approaches to epilepsy

Aabir Chakraborty and James T Rutka

• 抽象的な

医薬品の評価

Lacosamide for the treatment of partial-onset seizures

Matthew H Wong and Nathan B Fountain

• 抽象的な